Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells by Guy, M et al.
The colonic crypt is a constantly self-renewing tissue in which a
balance between proliferation, differentiation and cell death must
be precisely controlled in order to maintain normal tissue
homeostasis. In the normal colon, proliferating cells migrate up
the crypt where they differentiate and subsequently undergo what
is believed to be p53-independent apoptosis at the lumenal surface
(Gaverelli et al, 1992; Hall et al, 1994). This is distinct from the
p53-dependent apoptosis that occurs in response to DNA damage,
for example, and which is localized to the proliferating stem cell
compartment of the crypt (Merrit et al, 1994). The retinoblastoma
protein (pRb) has been implicated in cell cycle regulation, differ-
entiation and apoptosis in other tissue systems (Coppola et al,
1990; Haas-Kogan et al, 1995; Sellers and Kaelin, 1996), although
its role in the colon and in colorectal carcinogenesis remains
unclear. 
The Rb protein is encoded by the RB-1 tumour-suppressor gene,
and is a member of the ‘pocket protein’ family along with two
related proteins, p130 and p107. The term ‘pocket protein’ is
derived from the discovery that these 3 proteins have sequence
homology in their A/B pocket domain, which is a region of
tumorigenic mutations, viral oncoprotein binding and E2F interac-
tions (reviewed in Paggi et al, 1996). Cyclin-cdk complexes regu-
late the binding of the pocket protein/E2F complexes by
phosphorylating the pocket proteins in a cell cycle-dependent
manner (reviewed in Beijersbergen and Bernards, 1996). For
instance, the interaction of hypophosphorylated pRb with E2F-1
prevents entry into S phase (Weinberg, 1995). Hence pRb and the
other members of the pocket protein family perform an important
function in the co-ordination of the cell cycle and cell prolifera-
tion. 
Clues that Rb might play an important role in the differentiation
process came initially from studies in knock-out mice. These
revealed that RB-1 knockout mice die at around day 14.5 of gesta-
tion, and exhibit defective differentiation and extensive apoptosis
in the haematopoietic system, lens and nervous system (Clarke 
et al, 1992; Jacks et al, 1992; Lee et al, 1992; Zackenhaus et al,
1996), suggesting that Rb is required for the differentiation of
specific tissues. Additionally, in vitro experiments have shown
that hypophosphorylation of the Rb protein may play a role in the
differentiation of some cell types, e.g. human haematopoietic cells
(Furukawa et al, 1990), leukaemia cell lines (Chen et al, 1989),
PC12 neuronal cells (Kalman et al, 1993; Li et al, 1996) and
myoblast cell lines (Gu et al, 1993). Interestingly, while differenti-
ation in erythroleukaemia cells (Coppola et al, 1990; Richon et al,
1992), myocytes (Coppola et al, 1990; Endo and Goto, 1992), and
embryonal carcinoma cells (Slack et al, 1993) is associated with an
accumulation of RB-1 mRNA, the other pocket proteins do not
appear to play such a crucial role in differentiation. Indeed, mice
deficient for either p107 or p130 show no developmental defects
(Cobrinik et al, 1996), indicating that the pocket protein family
may functionally compensate for one another. 
Previous studies suggest an involvement of pRb in the regulation
of apoptotic cell death (reviewed in Dou and An, 1998).
Experiments using the human osteosarcoma cell line SAOS-2,
which lacks functional pRb, showed that radiation-induced apop-
totic cell death was high in the absence of Rb protein in compar-
ison to SAOS-2 cells transfected with wild-type pRb (Haas-Kogan
et al, 1995). Similarly Almasan et al (1995) reported that the
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targeted inactivation of the RB-1 gene in mouse embryonic fibro-
blasts induces apoptosis. Therefore, pRb appears to suppress apop-
tosis in some cell systems, perhaps through the sequestration of the
E2F-1 protein, which can induce apoptosis if over-expressed (Qin
et al, 1994; Field et al, 1996). In this case, pRb needs to be
removed or inactivated before apoptosis can occur. To support
this, a 30 kD protein has been detected in apoptotic cells harvested
from colon tumour cell lines, CMSV40 fibroblasts and BJA-B
lymphocyte cells, suggesting that the Rb protein is cleaved during
the apoptotic process (Browne et al, 1994; An and Dou, 1996).
Furthermore, cleavage at the C-terminus of pRb results in a p100
and ~5 kDa polypeptide (Chen et al, 1997). The p100 Rb protein
can still bind to E2F-1 and inhibit E2F-mediated transcriptional
activity, but its anti-apoptotic function is reduced, perhaps through
its inability to bind to the oncogene MDM2. Thus the growth-
suppressive and anti-apoptotic functions of pRb appear to be
distinct from one another. The notion that pRb functions can be
separated from one another has been explored previously, and
experimental evidence indicates that the multiple functions of pRb
can be genetically uncoupled, providing distinct functions in cell-
cycle control or in tissue-specific gene expression during differen-
tiation (reviewed in Yee et al, 1998). Mice with mutations of the
N-terminal region of Rb protein exhibit defects in muscle differen-
tiation, whilst retaining the ability to bind to E2F (Riley et al,
1997). Conversely, cells with pRb mutations in the pocket domain
are able to differentiate normally even when E2F binding is 
abrogated (Sellers et al, 1998). 
The functional loss of the Rb protein, by deletion or mutation,
has been implicated not only in retinoblastoma, but in many types
of tumour, including bladder, breast, lung and ovarian cancer
(Berns et al, 1995; Hiyana et al, 1995; Takano et al, 1995;
Miyamoto et al, 1996). However, loss or inactivation of the RB-1
gene in colorectal tumours is uncommon (Meling et al, 1991; Ali
et al, 1993); only up to 11% of colorectal carcinomas show allelic
loss on chromosome 13 (Wildrick and Bowman, 1994). Instead,
colorectal tumours have been reported to express significantly
higher levels of RB-1 mRNA than normal colonic mucosa (Gope
et al, 1990). This increase coincides with a 1.5–2.5 fold increase in
percentage of pRb phosphorylation (Gope and Gope, 1992), which
is thought to be due to over-expression of the Rb-related kinases
cdk2 and cdc2 (Yamamoto et al, 1995). In addition, Rb protein
associated with elevated levels of transcripts appears to be normal
size (4.7 kb) and functional (Ali et al, 1993), suggesting that
colorectal cancer cells retain functional pRb. 
There are few previous studies on the role of the Rb pocket
protein in differentiation and apoptosis of colonic epithelial cells.
One in vivo study reports that Rb protein staining was localized
preferentially to the midcrypt differentiation zone in normal
human colonic epithelium; while fully differentiated cells at the
top of the crypt were pRb negative (Ali et al, 1993). However, the
authors’ state that these results were not conclusive, as the possib-
ility of cross-reaction of the pRb antibody with other members of
the pocket protein family could not be ruled out. Therefore the aim
of this study was to investigate the regulation of expression of Rb
protein in relation to increased differentiation and induction of
apoptosis in colonic epithelial cells. Initially we studied the differ-
ential protein expression of Rb and the related pocket proteins
(p107 and p130) in the normal colonic crypt in vivo. Results
showed that down-regulation of the Rb protein correlated with 
the region of functional differentiation and apoptosis in the 
normal colonic crypt, and that Rb protein was highly expressed in
colorectal carcinomas. Therefore, we used an in vitro model
system to investigate the mechanism of regulation of pRb expres-
sion with increased differentiation in premalignant colorectal
epithelial cells (by maintenance at confluence or treatment with
the differentiation agent sodium butyrate). In addition we invest-
igated whether suppression of pRb function increased the suscept-
ibility of pre-malignant adenoma-derived cells to apoptosis. 
MATERIALS AND METHODS 
Immunostaining of normal human colonic crypts and
tumour tissue 
Formalin-fixed paraffin embedded tissues were used in this study.
These were retrieved from the archives of the Department of
Histopathology, Bristol Royal Infirmary. 10 samples of colorectal
adenocarcinomas (taken from colectomy specimens from 10
different patients) at various grades of differentiation were exam-
ined. In 4 of these cases adjacent mucosa which appeared morpho-
logically normal in H&E sections were also examined. A further 6
samples of normal mucosa were obtained from areas situated at
least 6 cm from the tumour mass in colectomy specimens. pRb C-
15 Antibody (Pharmingen) was used at a dilution of 1:2000, p130
(C-20) and p107 (C18) antibodies (Santa Cruz) were diluted
1:500. A Biotin Streptavidin amplified detection system was used.
For antigen retrieval the pRb and p130 sections were microwaved
at medium power for 20 minutes in citrate buffer, while the p107
sections were pressure cooked for 100 seconds in EDTA buffer.
For each antibody preliminary experiments were carried out to
establish optimal dilutions and antigen-retrieving protocol. For the
pRb antibody, positive staining of lymphocytes in the tissue exam-
ined provided a useful internal control. In a number of cases there
was poor and inconsistent staining of background lymphocytes.
These were excluded from the study. Blocking peptides for each
antibody (Pharmingen and Santa Cruz) were used to verify that
there was no cross-reactivity of antibodies (data not shown). Slides
were assessed by an independent pathologist. 
Cell culture 
Human colorectal adenoma and carcinoma-derived cell lines were
used in this study. PC/AA/C1 is a clonogenic, non-tumorigenic
adenoma cell line (Paraskeva et al, 1984), which has been con-
verted in vitro to a tumorigenic derivative cell line (tumorigenic in
nude mice) designated PC/AA/C1/SB10 (Williams et al, 1990).
These two cell lines consequently represent a relatively early and
late stage in the multi-step process of colorectal carcinogenesis.
Both cell lines were grown in conditioned medium (described in
Williams et al, 1990). S/RG/C2 is a clonogenic cell derived from a
sporadic tubular adenoma and grown in 20% FBS DMEM (Life
Technologies, UK) (Paraskeva et al, 1984). PC/JW2 is a carci-
noma-derived cell line (Paraskeva et al, 1984) which was main-
tained in 10% FBS DMEM. 
Infection of E7 cell lines 
The PC/AA/C1 cell line was infected with the HPV E7 oncopro-
tein using retroviral gene transfer (as described in Bond et al
(1999) for thyroid epithelial cells) and maintained in G418 selec-
tion medium at a concentration of 200 mg ml–1. The resultant cell
line was designated AA/C1/RE7, the corresponding vector control522 M Guy et al 
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AA/C1/NEO. E7 expression was verified by immunostaining with
HPV-16 E7 monoclonal antibody (Ciba Corning) (Jane Bond, data
not shown). It is important to note that both the HPV E7-infected
cell line (AA/C1/RE7) and vector control cell line (AA/C1/NEO)
were isolated from several hundred pooled colonies which had
survived the drug selection. 
Induction of differentiation using cell confluency 
Differentiation was induced by allowing the cells to grow to post-
confluency. Once confluent cells become non-cycling they begin
to differentiate as indicated by cell morphology. Triplicate flasks
of cells were grown to 50% confluency, 100% confluency, one
week post-confluent and two weeks post-confluent. At these time-
points the cell monolayers were trypsinized to single cells, and
samples prepared for Western blotting by the method described in
Williams et al (1999). 
Induction of differentiation using sodium butyrate 
Cells were seeded at a density of 2 ´ 106 per flask in triplicate
flasks and left to grow exponentially for 72 hours. A stock solution
of 100 mM sodium butyrate (Sigma, UK) was prepared in tissue
culture water and diluted in the appropriate medium to concentra-
tions of 1 to 3 mM (representing normal physiological concentra-
tions; Cummings, 1981). Cells were treated for 48 hours before
trypsinization to single cells. Control cultures were treated with
growth medium and tissue culture water only. 
Protein expression by SDS-PAGE 
Western samples of 1 ´ 106 cells were prepared by the method
described in Williams et al (1999). Proteins were resolved on 7.5%
polyacrylamide gels and transferred onto Immobilon-P poly-
vinylidene difluoride membranes (Millipore, MA). Rb protein was
detected by the monoclonal antibody Rb245 (Pharmingen), 
(which detects both hypophosphorylated and hyperphosphorylated 
forms of pRb), at a 1:1000 dilution and a horse-radish peroxidase-
conjugated goat anti-mouse secondary antibody (1:1000 dilution)
(Sigma, UK). This secondary antibody was also used for mono-
clonal anti-a-tubulin (Sigma, UK) which was diluted 1:10 000 to
control for loading. p107 and p130 proteins were detected using 
C-18 (1:200 dilution) and C-20 (1:500 dilution) polyclonal anti-
bodies respectively (Santa Cruz) and horse-radish peroxidase-
conjugated goat anti-rabbit secondary antibody (1:1000 dilution)
(Sigma, UK). Protein bands were visualized using the Amersham
enhanced chemiluminescence detection system following the
manufacturer’s protocol. 
Northern blotting 
1 ´ 107 cells were washed in PBS and total RNA was extracted
using the Qiagen (Chatsworth, CA) RNEasy minikit according to
the instructions of the manufacturer. 13 mg of total RNA was sep-
arated on a 0.9% agarose gel, containing 3% formaldehyde, and
transferred to a nylon membrane (Genescreen Plus, NEN Life
Sciences, MA). a-32P-dATP labelled probes for RB-1 (template
wtpRb cDNA was from Sybille Mittnacht, ICR, London) and 18S
loading control (template from Maria Davies, Dental School,
University of Bristol) were prepared using a random-primer DNA-
labelling kit (Stratagene, CA) and hybridized overnight at 68˚C.
Filters were washed to a final stringency of 0.2 ´ SSC/1% SDS (10
min, 68˚C) and bands visualized by autoradiography. 
Assessment of apoptosis 
The level of apoptosis was measured by the method described in
Williams et al (2000). Briefly, the level of apoptosis in cultured
epithelial cell lines was assessed by measuring the proportion of
cells that detached from the monolayer and were floating in the
medium, and by determining the fraction of these floating cells
that were apoptotic. The attached and floating cell populations
were stained with 5 mg ml–1 acridine orange in PBS, and analysed
by fluorescent microscopy for morphological features of apoptosis
(most obviously the characteristically condensed chromatin).
Analysis was carried out by an experienced observer unaware of
the cell type or treatment. The fraction of floating cells that were
apoptotic did not significantly vary between treated and control
untreated cell populations and therefore the number of floating
cells could be used as a measure of the induction of apoptosis. 
RESULTS 
Rb protein and related proteins p107 and p130 are
differentially expressed in the normal human colonic
crypt in vivo 
As differential expression of proteins along the axis of the normal
colonic crypt has previously given important clues as to their func-
tion in the colonic crypt (for example Avery et al, 1993; Williams
et al, 2000), the expression of pRb and related pocket proteins
(p107 and p130) was investigated for at least 10 sections from
different patients of normal colonic mucosa and tissue adjacent to
colon tumours where appropriate. Blocking peptides for each anti-
body were used as a control to ensure that antibody staining was
specific (refer to materials and methods, data not shown). Results
indicate that there is differential expression of all 3 pocket proteins
along the length of the normal human colonic crypt. p107 expres-
sion was confined to the base of the crypt, in the proliferation zone
(Figure 1B), and p130 expression was restricted to the top of the
crypts, coincident with the region of differentiation and apoptosis
(Figure 1C). These results are consistent with the putative roles of
the pocket proteins, as p107 is thought to play a role in cell prolif-
eration, and p130 is associated with maintenance of a different-
iated state (reviewed in Mulligan and Jacks, 1998). However, the
localization of the Rb protein was quite different from that
reported in other tissue types. Although the pRb antibody, which
detects both phosphorylated and unphosphorylated forms of the
protein, stained throughout the base and mid-crypt, expression was
found to be decreased towards the top of the crypt, coincident with
the region of differentiation and apoptosis (Figure 1A). Of further
interest, expression of the Rb protein was investigated in colo-
rectal adenocarcinomas (results obtained from a minimum of 10
sections from separate patients). In all tumours studied, Rb protein
expression was detectable with all cells staining strongly posi-
tively for pRb (Figure 1D), suggesting that expression of the Rb
protein is selected for in tumour progression. Regulation of pRb expression in colonic epithelial cells 523
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Figure 1 Immunostaining of normal human colonic epithelium tissue sections. (A) Rb protein expression in normal colonic epithelium using the Rb C-15
antibody (Pharmingen). Although clearly detected throughout the base and mid-crypt, pRb expression is decreased towards the lumenal surface of the colonic
crypt. (This antibody does not distinguish between hypophosphorylated and hyperphosphorylated forms of pRb). (B) p107 expression in normal colonic
epithelium using the C-18 antibody (Santa Cruz). p107 expression is detected at the base of the crypts coincident with the region of proliferation. (C) p130
expression in normal colonic epithelium using the C-20 antibody (Santa Cruz). The p130 protein is expressed towards the top of the crypt co-incident with the
region of differentiation and apoptosis. (D) An adenocarcinoma stained with the Rb C-15 antibody (Pharmingen), showing over-expression of pRb. Results are
representative of specimens taken from 10 different patients. Negative controls (blocking peptides) were used as described in the Materials and methods, to
ensure that antibody binding was specific 524 M Guy et al 
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An increase in differentiation status using cell
confluency results in a substantial decrease in Rb
protein expression in the PC/AA/C1 adenoma-derived
cell line, but not in the tumorigenic derivative
PC/AA/C1SB10 
Having established that Rb protein expression is decreased
towards the top of the crypt, we used an in vitro cell culture model
to study the mechanism of regulation of pRb expression with
increased colonic epithelial cell differentiation, as this has not been
previously reported. The cell lines used were the non-tumorigenic
adenoma-derived PC/AA/C1 cell line and a tumorigenic derivative
of the PC/AA/C1 cell line, designated PC/AA/C1/SB10. These
cell lines represent a well characterized in vitro model of the
adenoma to carcinoma sequence (Williams et al, 1990). FACs
analysis was used to show that all cell lines enter a G1 arrest when
confluent; there was between a 1.4 and 3.6 fold increase in the
G1/S ratio when cells become confluent, depending on the cell line
(data not shown). Cells were then left for a further 2 weeks, at
which stage the cell cultures show clear morphological changes
(doming) associated with functional differentiation of the epithe-
lial monolayer (referred to as post-confluent). ‘Domes’ appear as
the cells differentiate into columnar epithelial cells, which trans-
port fluid through their lumenal surface and out through their 
basal surface (Kirkland, 1985). Both the adenoma-derived
PC/AA/C1 and the tumorigenic PC/AA/C1/SB10 cell lines form
domes in post-confluent cultures (an example of a PC/AA/C1
doming culture is shown in Figure 2B). Western blot analysis of
PC/AA/C1 showed that sub-confluent cells express high levels of
Rb protein, which is present in both the hyper-and hypo-phospho-
rylated forms (Figure 3A). On reaching confluency there was a
shift from the hyper-phosphorylated to the hypo-phosphorylated
form (Figure 3A), coincident with induction of G1 arrest.
Interestingly, this was followed by a significant down-regulation
of Rb protein expression in 2-week post-confluent cultures
(Figure 3A). Furthermore, in a second adenoma-derived cell line,
S/RG/C2, a similar down-regulation of Rb protein expression was
seen when differentiation was increased in post-confluent cultures
(results not shown). In addition, although doming was detected
in the post-confluent cultures of the tumorigenic derivative
PC/AA/C1/SB10, the down-regulation of Rb protein expression
was notably less in this cell line (Figure 3B) and in the carcinoma-
derived cell line PC/JW2 (data not shown), suggesting that regula-
tion of Rb protein expression may be aberrant in the tumorigenic
cells. 
Treatment with the differentiation agent sodium
butyrate results in a decrease in Rb protein expression
in the adenoma cell line PC/AA/C1 but not the
tumorigenic derivative PC/AA/C1/SB10 
To further investigate Rb protein expression in differentiated
colonic epithelial cells, we examined the expression of pRb in a
second in vitro cell culture model of colonic epithelial cell differ-
entiation. The short-chain fatty acid sodium butyrate (NaBt), a
natural fermentation product of dietary fibre (Cummings, 1981)
A
B
Figure 2 Morphology of PC/AA/C1 cell line at different stages of confluency.
(A) Sub-confluent PC/AA/C1 cells. (B) Two-week post-confluent PC/AA/C1
cells showing doming of the cell monolayer. This morphological change is
seen when the cells are actively transporting fluid and indicates that the cells
have become differentiated and functional (Kirkland 1985) 
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Figure 3 The effect of increased confluency on pRb protein expression in
the human colorectal adenoma cell line (PC/AA/C1) and its tumorigenic
derivative (PC/AA/C1/SB10). (A) Western blot showing Rb protein expression
in the PC/AA/C1 adenoma cell line as the confluency of the cell cultures is
increased from 50% confluent to 2 weeks post-confluent. An increase in cell
confluency resulted in a switch to the hypophosphorylated form followed by a
down-regulation of Rb protein. The antibody used (Rb245, Pharmingen)
detects both hyperphosphorylated (110 kDa) and hypophosphorylated 
(105 kDa) forms of the protein. (Similar results were obtained for the S/RG/C2
adenoma derived cell line, data not shown.) (B) Western blot of Rb protein
expression in the PC/AA/C1/SB10 tumorigenic derivative when differentiation
status of the cells is increased by allowing the cells to become post-confluent.
PC/AA/C1/SB10 cells show no down-regulation in Rb protein expression,
suggesting that pRb is deregulated during tumour progression. (Similar
results were obtained for the PC/JW2 carcinoma derived cell line, data not
shown.) Blots were reprobed with anti-a-tubulin as a control for equal lane
loading. The results are typical of at least 3 independent experiments, where
pRb was reproducibly down-regulated during confluency in PC/AA/C1 but not
in the transformed variant PC/AA/C1/SB10 Regulation of pRb expression in colonic epithelial cells 525
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has been found to induce differentiation in a number of different
cell types including colonic cells (Leder and Leder, 1975; Prasad
and Sinha, 1976). Furthermore, it has previously been established
that NaBt can induce differentiation in colorectal cell lines, and
this induction of differentiation is evidenced by increased expres-
sion of the differentiation markers alkaline phosphatase (ALP) and
E-cadherin (Butt et al, 1997). On treatment with NaBt, an analog-
ous level of induction of both differentiation markers (ALP and 
E-cadherin) was detected in both adenoma- and carcinoma-
derived cell lines, indicating that an increase in differentiation 
was detectable in all cell lines (the tumorigenic cell lines
PC/AA/C1/SB10 and PC/JW2 as well as the non-tumorigenic
PC/AA/C1, S/RG/C2 cells) (Butt et al, 1997). Additionally it has
been established using FACs analysis that the G1/S ratio increases
in a dose-dependent manner in the colorectal cell lines used in our
study after 48 hours of NaBt treatment (approximately 1.5–3.2
fold, depending on cell line; Butt, 1996). Therefore the PC/AA/C1
adenoma cells and their tumorigenic derivative PC/AA/C1/SB10
cells were treated with doses of sodium butyrate (0–3 mM for 48
hours) which had previously been shown to induce differentiation,
and the Rb protein expression determined by Western analysis.
Figure 4A shows the down-regulation of Rb protein expression
with butyrate treatment in a dose-dependent manner in the cell line
PC/AA/C1. Similar results were found for the S/RG/C2 adenoma
cell line (data not shown). However, the tumorigenic derivative
cell line, PC/AA/C1/SB10, showed little or no down-regulation of
Rb protein when treated with butyrate (Figure 4B); similar results
were obtained for the tumour-derived cell line PC/JW2 (data not
shown). Again these results suggest that deregulation of pRb
expression may occur in the tumorigenic cells as Rb protein
expression is markedly down-regulated in pre-malignant
adenoma-derived cells but not in the tumorigenic cells, even
though the differentiation status of the cells is similarly increased
by NaBt treatment. 
The down-regulation of Rb protein expression is
regulated at the transcriptional level 
Having established that an increase in the differentiation status of
cells resulted in a down-regulation of Rb protein expression in the
adenoma-derived cell lines, we wished to determine whether
down-regulation of pRb was regulated at the transcriptional level,
or by post-transcriptional modification of the Rb protein. Total
RNA was extracted from sub-confluent (50% confluent) cells and
2 weeks post-confluent cultures, and RB-1 mRNA expression was
measured using Northern blotting analysis. Figure 5 shows a
decrease in RB-1 mRNA in the two adenoma cell lines; RB-1
mRNA is significantly decreased in the post-confluent S/RG/C2
adenoma derived cells (33%) and to a lesser extent in the in the 2
weeks post-confluent PC/AA/C1 cell line (24%). However, by
contrast, RB-1 mRNA expression fails to down-regulate in the 2
week post-confluent cells of the tumorigenic derivative adenoma
cell line PC/AA/C1/SB10 (Figure 5). This is consistent with the
failure of this cell line to down-regulate Rb protein expression as
the differentiation status of the cells is increased (Figures 3 and 4).
This is the first report that down-regulation of Rb protein expres-
sion in adenoma-derived cell lines with increased differentiation is
regulated via a transcriptional mechanism, and this regulation of
expression is aberrant in the tumorigenic cell line. 
Expression of the HPV E7 oncoprotein in the PC/AA/C1
cell line leads to increased spontaneous apoptosis and
an increased apoptotic response after DNA damage 
As down-regulation of pRb occurs at the top of the colonic crypt,
we wished to determine whether suppression of pRb function in
the PC/AA/C1 adenoma cell line was able to affect either the spon-
taneous rate of apoptosis and/or the cellular response to DNA
damage. To suppress pRb function the HPV E7 oncoprotein
(which binds to and inactivates pRb) was stably expressed in the
PC/AA/C1 cell line by retroviral infection, and expression was
verified by immunostaining with an E7 antibody (refer to methods,
data not shown). The resultant E7 cell line, AA/C1/RE7, and
vector control line, AA/C1/NEO, were both isolated from at least
several hundred colonies all expressing the appropriate E7 or
vector control. The PC/AA/C1 cell line was selected for these
experiments as it has a low endogenous spontaneous rate of
apoptosis, and is relatively insensitive to DNA damage-induced
110 kDa pRb
105 kDa pRb
110 kDa pRb
105 kDa pRb
A
B
0 mM 1 mM 2 mM 3 mM
Figure 4 Effect of sodium butyrate on Rb protein expression in the human
colonic adenoma cell line, PC/AA/C1 and the tumorigenic derivative cell line
PC/AA/C1/SB10. Western blots showing Rb protein expression (using the
Rb245 antibody, Pharmingen) after 48 hour treatment with the differentiation
agent sodium butyrate, at concentrations of up to 3 mM. (A) In the adenoma
cell line, PC/AA/C1, Rb protein expression decreased in a dose-dependent
manner. (Similar results were obtained for the S/RG/C2 adenoma derived cell
line, data not shown.) (B) The tumorigenic derivative cell line PC/AA/C1/SB10
showed no decrease in expression of Rb protein. (Similar results were
obtained for the PC/JW2 carcinoma derived cell line, data not shown.) Blots
were reprobed with anti-a-tubulin as a control for equal lane loading. The
results are typical of at least 3 independent experiments 
RB-1
18S
123456
2.26 1.53 1.81 1.38 2.39 2.41 RB-1/18S ratio
Figure 5 Effect of increasing confluency on RB-1 mRNA expression in
colonic adenoma and carcinoma cell lines. Expression of RB-1 mRNA in 50%
confluent cells and two week post-confluent cells. Lane 1, S/RG/C2 50%
confluent cells; lane 2, S/RG/C2 2-week post-confluent cells; lane 3,
PC/AA/C1 50% confluent cells; lane 4, PC/AA/C1 2-week post-confluent
cells, lane 5, PC/AA/C1/SB10 50% confluent cells; lane 6, PC/AA/C1/SB10 2-
week post-confluent cells. 18S was used to control for RNA loading. The ratio
of RB-1:18s RNA is shown under the appropriate lanes, as assessed by
densitometry. Expression is down-regulated in the S/RG/C2 (33%) and to a
lesser extent in the PC/AA/C1 adenoma cell line (24%), but not in the
transformed adenoma, PC/AA/C1/SB10. Data shown are representative of
results from duplicate experiments 526 M Guy et al 
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apoptosis after exposure to 5 Gy g radiation (Bracey et al, 1997).
The level of spontaneous apoptosis was determined in both the E7
expressing cell line (designated AA/C1/RE7) and vector control
cell line (designated AA/C1/NEO) by assessing the attached and
floating cell yields from exponentially growing cultures after 72
hours. As we and others have described previously, the level of
apoptosis in cultured epithelial cell lines can be assessed by
measuring the proportion of cells that have detached from the
monolayer and are floating in the medium and by determining the
fraction of these floating cells that are apoptotic using acridine
orange staining to confirm morphological features of apoptosis
(Hague et al, 1993; Tsujii and Dubois 1995; refer to materials and
methods section). A 1.5-fold increase was observed in spontan-
eous apoptosis in the AA/C1/RE7 cell line when compared to the
vector control cell line (data not shown). In addition, cells
(AA/C1/RE7 and AA/C1/NEO) were irradiated with 5 Gy g radia-
tion, and attached and floating cell yields determined after 72
hours. Results shown in Figure 6 show an increase in g-radiation-
induced apoptosis when Rb protein function is compromised by
the expression of the E7 protein, (mean of 3 independent experi-
ments). These results suggest that suppression of pRb function
does increase both the rate of spontaneous apoptosis and the level
of irradiation-induced apoptosis in the PC/AA/C1 cell line. 
DISCUSSION 
The Rb protein is known to play an important role in the cell 
cycle regulation, differentiation and apoptotic pathways in many
different cell systems. As these processes are critical in the mainten-
ance of tissue homeostasis in the colonic crypt, it is somewhat
surprising that relatively little is known about the specific role of
the Rb protein in the colon. The differential expression of other
proteins within the colonic crypt, for example Bcl-2 (Hague et al,
1994) Bax, (Krajewski et al, 1994), TGFb, (Avery et al, 1993), and
IGFBP-3 (Williams et al, 2000), have given important clues as to
their function in the regulation of crypt architecture. Therefore we
investigated the expression of pRb in the normal colonic crypt in
vivo, and the mechanism of regulation of pRb expression with
differentiation and apoptosis in vitro. Unlike previous reports (Ali
et al, 1993; Kohn et al, 1997), we found that expression of the Rb
protein in human colonic epithelial cells in vivo was not maximal
in the differentiation zone, but that Rb protein was expressed
throughout the base and mid crypt, and decreased significantly at
the top of the normal crypt. Interestingly, during preparation of this
manuscript, a study by Yamamoto et al (1999) was published in
which down-regulation of Rb protein was also found at the top of
the human colonic crypt. Using in vitro models to study the regu-
lation of pRb expression in premalignant colonic epithelial cells,
we found that the Rb protein was down-regulated in colonic
adenoma-derived cell lines as differentiation was increased using
both confluency and the differentiation agent sodium butyrate.
However, interestingly, although differentiation could be induced
in the tumorigenic cell line PC/AA/C1/SB10, the Rb protein was
not significantly down-regulated. This finding suggests that
suppression of pRb expression, although associated with, is not
required for induction of differentiation and that regulation of
the pRb expression levels is aberrant in tumorigenic cells. The
aberrant expression in tumorigenic cells correlates with in vivo
tumour tissue staining, where pRb is highly expressed throughout
colorectal carcinomas. These results are contrary to findings in
other in vitro cell systems such as normal adipose tissue, myocytes
and haematopoietic cells, where differentiation is associated with
the accumulation of RB-1 mRNA (Coppola et al, 1990; Endo and
Goto 1992; Richon et al, 1992; Slack et al, 1993; Chen et al, 1996),
and where inactivation of the Rb protein is associated with tumor-
igenesis (Berns et al, 1995; Hiyana et al, 1995; Takano et al, 1995;
Miyamoto et al, 1996). A major difference between the colon and
other tissues is the notable lack of RB-1 deletion or mutation in
colorectal cancer (Meling et al, 1991; Ali et al, 1993) indicating
that the inactivation of RB-1 is not required for the development of
colorectal tumorigenesis. In addition, the rise in the level of RB-1
mRNA in colonic tumours compared to that in normal colonic
mucosa (Gope et al, 1990), together with the associated increase in
pRb phosphorylation (Gope and Gope, 1992) suggest that the
active Rb protein is retained and indeed up-regulated in colonic
tumorigenesis. This is further supported by the fact that Rb protein
associated with elevated levels of transcripts appears to be normal
size (4.7 kb) and functional (Ali et al, 1993), inferring that
colorectal cancer cells retain functional pRb. 
The role of Rb as a survival factor has been explored recently in
more detail in a number of cell types; when the RB-1 gene or Rb
protein was absent from cells, or non-functional, apoptotic cell
death increased (Almasan et al, 1995; Haas-Kogan et al, 1995),
and mice deficient for RB-1 are nonviable as a result of widespread
apoptosis (Lee et al, 1992). In the current investigation we have
shown that the human papilloma virus oncoprotein E7, which is
known to bind and inactivate pRb, can increase both spontaneous
and DNA damage-induced apoptosis in colonic adenoma-derived
cells, suggesting that the suppression of the pRb expression in
differentiated cells makes the cells more susceptible to apoptosis.
Furthermore, cleaved products of the Rb protein have been
detected in apoptotic cells harvested from our colonic cell lines
(Browne et al, 1994), showing that cleavage of the Rb protein
occurs during the apoptotic process. Browne et al (1994)
suggested a role for pRb in controlling cell numbers in the colon,
and hypothesize that pRb may act as a survival factor in the 
colon. Our evidence further suggests that pRb is acting as a
survival factor in colonic epithelium; we propose that Rb protein
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Figure 6 Effect of suppressing pRb function on apoptosis, by stably
expressing the HPV E7 oncoprotein in the AA/C1 cell line. Graph shows
radiation-induced apoptosis in E7-infected PC/AA/C1 cells, AA/C1/RE7,
72 hours after exposure to 5 Gy g-radiation, compared to their vector control,
AA/C1/NEO. Percentage of floating cells is used as a measurement of
apoptosis (refer to Methods). The results shown represent the mean of 3
independent experiments ± S.D expression is suppressed through a transcriptional mechanism as
the cells near the top of the crypt, in order to ‘prime’ them for
apoptotic cell death when they reach the gut lumen. Cells that
retain pRb are protected from apoptosis because of the anti-apop-
totic function of the Rb protein (Haas-Kogan et al, 1995). In
support of this, Yamamota et al (1999) found that by targeting RB-
1 mRNA in HCT116 colon carcinoma cells with an anti-sense
oligodeoxynucleotide, they could bring about a 70% decrease in
the level of Rb protein expression which correlated with induction
of apoptosis. This hypothesis provides an explanation for the high
expression of functional Rb protein in colonic tumour cells, as
retaining Rb protein would allow these cells to escape
programmed cell death. Therefore our results, in pre-malignant
cells using HPV-E7 to suppress pRb function, are in agreement
with the findings of Yamamato et al (1999, published during
preparation of this manuscript). This is of importance as both inde-
pendent studies have shown that, contrary to the traditional role of
pRb as a tumour suppressor, expression of the Rb protein may
actually result in a growth advantage for colorectal cells. 
In summary, Rb protein expression is down-regulated towards
the top of the normal colonic crypt. Using in vitro models, we have
shown that pRb expression in differentiated cells is transcription-
ally regulated, and this level of regulation is reduced in tumori-
genic cells. The functional consequence of pRb down-regulation is
to increase the cellular response to apoptotic signals. Therefore
down-regulation of pRb at the top of the colonic crypt may be
important in ‘priming’ the cells for apoptosis at the lumenal
surface, suggesting a role for pRb in the maintenance of normal
tissue homeostasis of the colon. Expression of functional pRb in
colorectal tumours, contrary to the traditional role of Rb as a
tumour suppressor protein, would provide the cells with a survival
advantage, allowing evasion of apoptotic signalling and hence
leading to aberrant cell survival. 
Finally, as suppression of pRb function by the HPV-E7 viral
oncoprotein increased DNA damage-induced apoptosis, the expres-
sion of Rb protein by colorectal carcinoma cells may contribute to
the resistance of tumours to current therapies. Hence, Rb protein
may be a potentially important target for therapeutic intervention.
As pRb acts as a survival factor in human colorectal tumour cells,
then suppression of the Rb protein expression may increase the
sensitivity of the cells to radiotherapy and/or chemotherapy,
making treatment of colorectal cancer more effective. 
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